Project Details
Description
DESCRIPTION (provided by applicant):
Benign prostatic hyperplasia (BPH) is the most common affliction of men over
the age of 50. Despite numerous innovations in therapy for BPH including
medical and minimally invasive surgical therapies (MIST), transurethral
resection of the prostate (TURP) remains the most effective. In part, the
shortcomings of MIST have been the lack of uniform baseline study entry
criteria, poor elucidation of baseline criteria aid in therapeutic success and
paucity of long-term data. Furthermore, there have been no studies that have
attempted to stratify response to therapy based on ethnic variability. Recent
data suggests that there may be varying distribution of symptoms, objective
diagnoses, and functional / morphologic aspects of the prostate among different
ethnic groups. Do minimally invasive alternative surgical therapies result in
alternating levels of success among different ethnic groups?
The Prostate Center at the New York Presbyterian Medical Center evaluates and
treats an ethnically diverse group of more than 1,000 men per year with lower
urinary tract symptoms secondary to BPH. In addition it has access to and
currently employs all FDA approved MIST procedures, including transurethral
microwave thermotherapy, TUNA, interstitial laser, water induced thermotherapy,
holmium laser prostatectomy and electrovaporization. We propose to examine the
role of MISTs designed to treat BPH a multi - ethnic group. The goals of this
clinical trial are to determine the urodynamic changes in bladder function and
outlet obstruction in patients with BPH treated by MIST. Parameters to be
analyzed include peak detrusor pressure during voiding, detrusor pressure
during maximal flow, Shafer resistance curves, Abrams - Griffiths contractility
index and detrusor contraction duration. These parameters will be assessed to
determine prognostic significance and correlated with long term improvement as
determined by changes in the American Urologic Association Symptom Score
(AUASx), uroflow and post void residual urine.
Specifically, this study aims to evaluate in a highly diverse multi - ethnic
population:
1. Urodynamic contractility and resistance parameters which change
significantly after MIST
2. Baseline urodynamic parameters which may predict improved outcome after MIST
3. The success of various types of MIST in treating BPH in African - American,
Hispanic and Caucasian men.
Status | Finished |
---|---|
Effective start/end date | 9/30/01 → 6/30/09 |
Funding
- National Institute of Diabetes and Digestive and Kidney Diseases: US$392,602.00
- National Institute of Diabetes and Digestive and Kidney Diseases: US$1,427,618.00
- National Institute of Diabetes and Digestive and Kidney Diseases: US$100,000.00
- National Institute of Diabetes and Digestive and Kidney Diseases: US$250,000.00
- National Institute of Diabetes and Digestive and Kidney Diseases: US$356,458.00
ASJC Scopus Subject Areas
- Urology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.